Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Symrise stock upgraded to hold with a higher price target

EditorAhmed Abdulazez Abdulkadir
Published 08/03/2024, 14:28
Updated 08/03/2024, 14:28
© Reuters.

On Friday, Symrise AG (SY1:GR) (OTC: SYIEY) received an upgrade from CFRA, with the firm shifting its recommendation from Sell to Hold and increasing the 12-month price target to €110.00 ($1 = €0.91), up from the previous target of €90.00.

The adjustment comes after Symrise reported a 7.9% organic sales growth for 2023, which aligns with expectations for high single-digit sales growth.

Symrise's earnings before interest, taxes, depreciation, and amortization (EBITDA) for 2023 stood at €903.5 million, a slight decrease from €921.5 million in 2022. The decline was attributed to a 90 basis point reduction in the margin to 19.1% on a normalized basis.

Despite this dip, the company is projecting ambitious sales targets, aiming for €5.5 billion to €6.0 billion by the end of 2025, and €7.5 billion to €8.0 billion by 2028. Furthermore, Symrise is committed to maintaining its EBITDA margin target between 20% and 23% up to 2025.

The firm's upgrade reflects a valuation based on a price-to-earnings (P/E) ratio of 33 times for the year 2024, which is close to Symrise's five-year average P/E multiple of approximately 35 times. CFRA's revised stance on the stock is influenced by the company's solid performance, which is seen as balanced against the backdrop of uncertainties stemming from ongoing regulatory investigations.

The upgrade also includes CFRA's earnings per share (EPS) estimates for Symrise, which are set at €3.30 for 2024 and €3.80 for 2025. The new Hold rating indicates a neutral perspective on the stock's future performance, suggesting that the firm's strong results have been adequately factored into the current valuation.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.